The ESCMID Study Group for Viral Hepatitis (ESGVH) is deeply committed to advancing knowledge on viral hepatitis. Uniting members from all over the globe, they are dedicated to:
Updates in viral hepatitis in 2024 – summary of education, research and leadership activities of the ESCMID Study Group for Viral Hepatitis (ESGVH).
Săndulescu O, Hasanoğlu İ, Matičič M. GERMS. 2024;14(4):320-321
The spectrum of esophagitis in patients living with HIV - a scoping review.
Olariu MC, Olariu MH, Iancu AM, Săndulescu O, Streinu-Cercel A, Barbu EC, Şahin GÖ, Borcan AM, Cruceru MM, Simoiu M; ESCMID Study Group for Viral Hepatitis (ESGVH). Germs. 2024 Jun 30;14(2):188-196
Communicable Episode 06: “Sneaky viruses”- an update on hepatitis B & C before World Hepatitis Day.
Hostettler, K, Matičič, M, Săndulescu, O, Huttner, A. CMI Communications, Volume 1, Issue 3, 105048
Global vaccination against hepatitis E virus: position paper from the European society of clinical microbiology and infectious diseases viral hepatitis study group.
Dudman S, Zerja A, Hasanoğlu İ, Ruta S, van Welzen B, Nicolini LA, Yonga P, Øverbø J, Rawat S, Habibovic S, Kim TB, Rivero-Juarez A; ESGVH members. Clin Microbiol Infect. 2024 Nov 15:S1198-743X(24)00542-1.
Exposure to biological fluids in dental practice – Narrative review on appropriate risk assessment to guide post-exposure management.
Săndulescu M, Nicolescu MI, Funieru C, Şahin GÖ, Săndulescu O and ESCMID Study Group for Viral Hepatitis (ESGVH). Pathogens. 2023;12(7):968.
COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes.
Said ZNA, El Habashy SA, Zaky S and ESCMID Study Group for Viral Hepatitis (ESGVH). World J Gastroenterol. 2023;29(7):1123–1130.
ESGVH AMM webinar on Atypical serological tests and their interpretation in Hepatitis B Viral infection
19 December 2024, 15:00-16:00 CET
Management of HBV and HCV in transplant patients
9 December 2024, 16:00 CET
Chair: İmran Hasanoglu
Speakers: Harrys Antonio Torres and Paolo Antonio Grossi
ESGVH: Hepatitis C Virus in Special and Vulnerable Populations
25 November 2024, 13:00-14:00 CET
Breaking the Wall on Hepatitis A and E Vaccination: Should we change current recommendations?
18 December 2023
If you have questions or comments for our study group, we warmly invite you to contact us!